Could a herbal granule help treat stomach infection and fatty liver together?
NCT ID NCT07159412
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether adding a traditional Chinese medicine granule (Huazhi Rougan) to standard antibiotics can better treat both H. pylori infection and metabolic-associated fatty liver disease (MASH). About 286 adults with both conditions will receive either the herbal granule or a placebo, plus a two-week course of vonoprazan and amoxicillin. The main goal is to see if the combination improves H. pylori eradication rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Huazhi Rougan Granule (a traditional Chinese medicine granule) combined with vonoprazan and amoxicillin (antibiotics)
What this could lead to
If it works, this could offer a new way to treat both H. pylori infection and fatty liver disease at the same time, potentially improving outcomes for people with both conditions.
What could go wrong
This is an early-stage trial with no phase designation, so results are uncertain. The herbal granule may not add benefit over standard antibiotics, and side effects are not yet well understood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••